SCHEMBL771737

SCHEMBL771737

NC(CC(=O)OP(=O)(O)O)C(=O)OP(=O)(O)O

nearest known ligand 0.39

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CA4 P22748 1/20 0.39
▸ PEPD P12955 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9807834 1.00 CA4 (0.39) CA4PEPD
SCHEMBL28292794 0.83 CA4 (0.33) CA4
SCHEMBL4297049 0.83 CA4 (0.39) CA4PEPD
SCHEMBL28355439 0.83 CA4 (0.44) CA4PEPD
SCHEMBL771738 0.83 CA4 (0.39) CA4PEPD
SCHEMBL771739 0.83 CA4 (0.39) CA4PEPD
SCHEMBL60233 0.83 GRIK1 (0.42) —
SCHEMBL27195667 0.83 GRIK1 (0.42) —
SCHEMBL1890691 0.82 CYP2D6 (0.31) —
Water SCHEMBL28143134 0.82 CA4 (0.43) CA4PEPD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 231 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220260583-A1 CHEMOPROTEOMIC PROFILING OF PROTEIN ELECTROPHILIC AND OXIDATIVE POST-TRANSLATIONAL MODIFICATIONS Zenagem, LLC 2022-08-18 — — US claimed
US-11226337-B2 Chemoproteomic profiling of protein electrophilic and oxidative post-translational modifications Zenagem, LLC (US) 2022-01-18 — — US claimed
US-20190204336-A1 CHEMOPROTEOMIC PROFILING OF PROTEIN ELECTROPHILIC AND OXIDATIVE POST-TRANSLATIONAL MODIFICATIONS Zenagem, LLC 2019-07-04 — — US claimed
CN-103384809-B For method and the component of thermal energy storage Renewable Energy System Technology (TFRES) SDN BHD (BE) 2016-01-20 — — CN claimed
CN-103384809-A Methods and components for thermal energy storage DUCHEYNE WOUTER 2013-11-06 — — CN claimed
US-6495356-B1 BERYLLIUM ATOM IS COMPLEXED WITH FLUORINE LIGANDS IN LIEU OF A PHOSPHATE GROUP AT PHOSPHORYLATION SITE; BEFX REACTS WITH CARBOXYL GROUP TO MIMIC AN ACYL PHOSPHATE LINKAGE; FORMED IN THE SUBSTANTIAL ABSENCE OF A NUCLEOSIDE PHOSPHATE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2002-12-17 — — US claimed
WO-2001040268-A2 BERYLLOFLUORIDE ANALOGUES OF ACYL PHOSPHATE POLYPEPTIDES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2001-06-07 — — WO claimed
CN-122059901-A 1,3, 4-Oxadiazole compound and preparation method and application thereof 成都大学 2026-05-19 — — CN disclosed
EP-3957736-B1 PRODUCTION OF ODD CHAIN FATTY ACID DERIVATIVES IN RECOMBINANT MICROBIAL CELLS GENOMATICA INC (US) 2025-08-06 — — EP disclosed
CN-120041475-A Lysine artificial operon and application thereof 齐齐哈尔龙江阜丰生物科技有限公司 2025-05-27 — — CN disclosed
US-20250146034-A1 Multi-Mechanistic Channeling Within a Biocatalytic Cascade for the Production of 1,3-Diaminopropane THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY 2025-05-08 — — US disclosed
CN-118638707-B Corynebacterium glutamicum with high yield of exendin and application thereof 杭州佳嘉乐生物技术有限公司 2025-04-04 — — CN disclosed
WO-2024206168-A9 BIOPRODUCTION OF SULFUR-CONTAINING COMPOUNDS NATÁUR LLC (US) 2024-10-31 — — WO disclosed
WO-1994000493-A1 MEMBRANE-ASSOCIATED IMMUNOGENS OF MYCOBACTERIA KAPOOR ARCHANA (US) 1994-01-06 — — WO disclosed
EP-0572529-A1 APTAMER SPECIFIC FOR BIOMOLECULES AND METHOD OF MAKING GILEAD SCIENCES, INC. (US) 1993-12-08 — — EP disclosed
WO-1993019170-A1 SELECTION METHODS WOHLSTADTER JACOB NATHANIEL (US) 1993-09-30 — — WO disclosed
WO-1993012076-A1 REAGENTS FOR AUTOMATED SYNTHESIS OF PEPTIDE ANALOGS CORVAS INTERNATIONAL INC. (US) 1993-06-24 — — WO disclosed
US-4307192-A CULTURING ISOPENICILLINS IN CEPHALOSPORIUM MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1981-12-22 — — US disclosed
US-4248966-A FROM TRIPEPTIDES IN CEPHALOSPORIUM EXTRACT MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1981-02-03 — — US disclosed
US-4178210-A Accellular synthesis of cephalosporins MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1979-12-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190204336-A1 CHEMOPROTEOMIC PROFILING OF PROTEIN ELECTROPHILIC AND OXIDATIVE POST-TRANSLATIONAL MODIFICATIONS PTMS, CHAMP1, STUB1 CA4 3191/4885PEPD 2356/4885
US-11226337-B2 Chemoproteomic profiling of protein electrophilic and oxidative post-translational modifications PTMS, CHAMP1, STUB1 CA4 3191/4885PEPD 2356/4885
US-20220260583-A1 CHEMOPROTEOMIC PROFILING OF PROTEIN ELECTROPHILIC AND OXIDATIVE POST-TRANSLATIONAL MODIFICATIONS STUB1, PTMS, TMT1A CA4 3650/4885PEPD 2389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback